| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.25 | 6e-06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.24 | 0.002 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.24 | 0.0009 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0009 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.005 |